Probabilistic chemotherapy in knee and hip replacement infection: the place of linezolid
Authors:
- the CRIOGO (Centre de Référence des Infections Ostéo-articulaires du Grand Ouest) Study GroupTGthe CRIOGO (Centre de Référence des Infections Ostéo-articulaires du Grand Ouest) Study Group
- Luc DerocheLDLuc Deroche
- 15 June 2019
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 38 (9) , 1659-1663
Abstract
Prosthetic joint infection (PJI) can occur with a wide range of microorganisms and clinical features. After replacement surgery of prosthetic joint, prescription of probabilistic broad-spectrum antimicrobial therapy is usual, while awaiting microbial culture results. The aim of our study was to describe the antibiotic susceptibility of microorganisms isolated from hip and knee PJI. The data were collected to determine the best alternative to the usual combination of piperacillin-tazobactam (TZP) or cefotaxime (CTX) and vancomycin (VAN). Based on a French prospective, multicenter study, we analyzed microbiological susceptibility to antibiotics of 183 strains isolated from patients with confirmed hip or knee PJI. In vitro susceptibility was evaluated: TZP+VAN, TZP+linezolid (LZD), CTX+VAN, and CTX+LZD. We also analyzed resistance to different antibiotics commonly used as oral alternatives. Among the 183 patients with PJI, 62 (34%) had a total knee prosthesis, and 121 (66%) a hip prosthesis. The main identified bacteria were Staphylococcus aureus (32.2% of isolates), coagulase-negative staphylococci (27.3%), Enterobacteriaceae (14.2%), and Streptococcus (13.7%). Infections were polymicrobial for 28 (15.3%) patients. All combinations were highly effective: CTX+VAN, CTX+LZD, TZP+VAN, and TZP+LZD (93.4%, 94%, 98.4%, and 98.9% of all cases respectively). Use of LZD instead of VAN in combination with a broad-spectrum beta-lactam covers almost all of the bacteria isolated in PJI. This association should be considered in probabilistic chemotherapy, as it is particularly easy to use (oral administration and no vancomycin monitoring).Keywords
Funding Information
- French Ministry of Health (API/ N/041)
This publication has 24 references indexed in Scilit:
- Evaluation of 16S rRNA Gene PCR Sensitivity and Specificity for Diagnosis of Prosthetic Joint Infection: a Prospective Multicenter Cross-Sectional StudyJournal of Clinical Microbiology, 2014
- Cost-Effectiveness of Linezolid versus Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Confirmed Nosocomial Pneumonia in ChinaValue in Health Regional Issues, 2014
- Clinical Population Pharmacokinetics and Toxicodynamics of LinezolidAntimicrobial Agents and Chemotherapy, 2014
- The emerging problem of linezolid-resistant StaphylococcusJournal of Antimicrobial Chemotherapy, 2012
- Resistance to Linezolid Caused by Modifications at Its Binding Site on the RibosomeAntimicrobial Agents and Chemotherapy, 2012
- Recommendations for bone and joint prosthetic device infections in clinical practice (prosthesis, implants, osteosynthesis)Medecine Et Maladies Infectieuses, 2010
- Decreased Susceptibility to Teicoplanin and Vancomycin in Coagulase-Negative Staphylococci Isolated from Orthopedic-Device-Associated InfectionsJournal of Clinical Microbiology, 2010
- Resistance to Linezolid Is Mediated by thecfrGene in the First Report of an Outbreak of Linezolid‐ResistantStaphylococcus aureusClinical Infectious Diseases, 2010
- Toxicity of extended courses of linezolid: results of an Infectious Diseases Society of America Emerging Infections Network surveyDiagnostic Microbiology and Infectious Disease, 2008
- VancomycinJournal of Infusion Nursing, 2003